Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

被引：10

作者：

Mawad, Raya ^{[1
,2
]}

Lionberger, Jack M. ^{[3
]}

Pagel, John M. ^{[1
,2
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA

[2] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA

[3] St Louis Univ, Dept Med, Div Hematol Oncol, St Louis, MO 63103 USA

来源：

CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 2013年 / 8卷 / 02期

关键词：

Acute myeloid leukemia; Allogeneic hematopoietic cell transplant; Relapse; Strategies; VERSUS-HOST-DISEASE; ACUTE MYELOGENOUS LEUKEMIA; BONE-MARROW-TRANSPLANTATION; DONOR LEUKOCYTE INFUSIONS; WT1 PEPTIDE VACCINATION; PROGNOSTIC-SIGNIFICANCE; OLDER PATIENTS; CYTOGENETIC ABNORMALITIES; HEMATOLOGIC MALIGNANCIES; COMPLETE REMISSION;

D O I：

10.1007/s11899-013-0153-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of acute myeloid leukemia (AML) is expected to increase in conjunction with our ageing population. Although it is proving to be a heterogeneous disease process, the only treatment with proven survival benefit for poor risk AML remains allogeneic hematopoietic cell transplant. Although this is presumed to be a curative strategy, many patients relapse after transplant, prompting us to examine various ways that we can improve outcomes. These efforts involve every step of AML diagnostics and therapy, including the intricate processes of conditioning, graft manipulation and immunomodulation. The hope is that improvement in these steps will ultimately improve survival and decrease relapse rates for AML patients after transplant.

引用

页码：132 / 140

页数：9

共 58 条

[31] Transplantation of allogeneic CD34+selected cells followed by early T-cell add-backs:: favorable results in acute and chronic myeloid leukemia [J].

Kobbe, G ;

Fenk, R ;

Neumann, F ;

Bernhardt, A ;

Steidl, U ;

Kondakci, M ;

Graef, T ;

Aivado, M ;

Vaupel, M ;

Huenerlituerkoglu, AN ;

Kronenwett, R ;

Pape, H ;

Hildebrand, B ;

Germing, U ;

Haas, R .

CYTOTHERAPY, 2004, 6 (06) :533-542

[32] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].

KOLB, HJ ;

SCHATTENBERG, A ;

GOLDMAN, JM ;

HERTENSTEIN, B ;

JACOBSEN, N ;

ARCESE, W ;

LJUNGMAN, P ;

FERRANT, A ;

VERDONCK, L ;

NIEDERWIESER, D ;

VANRHEE, F ;

MITTERMUELLER, J ;

DEWITTE, T ;

HOLLER, E ;

ANSARI, H .

BLOOD, 1995, 86 (05) :2041-2050

[33] Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation [J].

Levine, JE ;

Braun, T ;

Penza, SL ;

Beatty, P ;

Cornetta, K ;

Martino, R ;

Drobyski, WR ;

Barrett, AJ ;

Porter, DL ;

Giralt, S ;

Leis, J ;

Holmes, HE ;

Johnson, M ;

Horowitz, M ;

Collins, RH .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :405-412

[34] Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution [J].

Li, Ning ;

Matte-Martone, Catherine ;

Zheng, Hong ;

Cui, Weiguo ;

Venkatesan, Srividhya ;

Tan, Hung Sheng ;

McNiff, Jennifer ;

Demetris, Anthony J. ;

Roopenian, Derry ;

Kaech, Susan ;

Shlomchik, Warren D. .

BLOOD, 2011, 118 (22) :5965-5976

[35] Relapse of leukemia and lymphoma after marrow transplant: A review of cases with extramedullary relapse [J].

Linn, YC ;

Goh, YT ;

Tan, HCP .

LEUKEMIA & LYMPHOMA, 2000, 38 (1-2) :137-146

[36] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia [J].

Lowenberg, Bob ;

Ossenkoppele, Gert J. ;

van Putten, Wim ;

Schouten, Harry C. ;

Graux, Carlos ;

Ferrant, Augustin ;

Sonneveld, Pieter ;

Maertens, Johan ;

Jongen-Lavrencic, Mojca ;

von Lilienfeld-Toal, Marie ;

Biemond, Bart J. ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

Verdonck, Leo F. ;

Beck, Joachim ;

Doehner, Hartmut ;

Gratwohl, Alois ;

Pabst, Thomas ;

Verhoef, Gregor .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1235-1248

[37] HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide [J].

Luznik, Leo ;

O'Donnell, Paul V. ;

Symons, Heather J. ;

Chen, Allen R. ;

Leffell, M. Susan ;

Zahurak, Marianna ;

Gooley, Ted A. ;

Piantadosi, Steve ;

Kaup, Michele ;

Ambinder, Richard F. ;

Huff, Carol Ann ;

Matsui, William ;

Bolanos-Meade, Javier ;

Borrello, Ivan ;

Powell, Jonathan D. ;

Harrington, Elizabeth ;

Warnock, Sandy ;

Flowers, May ;

Brodsky, Robert A. ;

Sandmaier, Brenda M. ;

Storb, Rainer F. ;

Jones, Richard J. ;

Fuchs, Ephraim J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) :641-650

[38] Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies [J].

Magenau, John ;

Tobai, Hiromi ;

Pawarode, Attaphol ;

Braun, Thomas ;

Peres, Edward ;

Reddy, Pavan ;

Kitko, Carrie ;

Choi, Sung ;

Yanik, Gregory ;

Frame, David ;

Harris, Andrew ;

Erba, Harry ;

Kujawski, Lisa ;

Elenitoba-Johnson, Kojo ;

Sanks, Jennifer ;

Jones, Dawn ;

Paczesny, Sophie ;

Ferrara, James ;

Levine, John ;

Mineishi, Shin .

BLOOD, 2011, 118 (15) :4258-4264

[39] Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity [J].

Mailänder, V ;

Scheibenbogen, C ;

Thiel, E ;

Letsch, A ;

Blau, IW ;

Keilholz, U .

LEUKEMIA, 2004, 18 (01) :165-166

[40] Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation [J].

Metzelder, Stephan ;

Wang, Ying ;

Wollmer, Ellen ;

Wanzel, Michael ;

Teichler, Sabine ;

Chaturvedi, Anuhar ;

Eilers, Martin ;

Enghofer, Erich ;

Neubauer, Andreas ;

Burchert, Andreas .

BLOOD, 2009, 113 (26) :6567-6571

← 1 2 3 4 5 6 →